Personalized Testing and Supplements Market Size to Attain USD 7.74 Billion by 2034

The global personalized testing and supplements market size is projected to reach approximately USD 7.74 billion by 2034, expanding from USD 5.39 billion in 2025 at a robust CAGR of 16.22% (2025–2034).

Growth is fueled by advancements in artificial intelligence, digital health tools, and the increasing reliance on genomics and biomarkers to optimize individual wellness. As consumer awareness matures, the sector welcomes bold opportunities, regulatory innovation, and novel business models, fundamentally reshaping preventive healthcare and personalized nutrition worldwide.

Introduction: Supercharged Growth Powered by Personalized Analytics

Between 2025 and 2034, the personalized testing and supplements market is set to transform how preventive medicine and wellness are delivered at both scale and granularity. The industry benefits from unprecedented consumer appetite for data-driven health solutions, harnessing genetic sequencing, microbiome analysis, biomarker profiling, and AI-powered applications. As personalized algorithms decode individual biological needs, consumers gain access to tailored supplements and smart testing kits—making health optimization both actionable and relevant.

Personalized Testing and Supplements Market Key Insights

• Global Market Value (2025): USD 5.39 billion

• Forecasted Value (2034): USD 7.74 billion

• CAGR (2025–2034): 16.22%

• Dominant Region (2024): North America (40% market share)

• Fastest-Growing Region: Asia Pacific (projected 20% CAGR)

• Leading Segment: Nutrition Supplements (65% market share, 2024)

• Top Service: Genetic Testing Services (40% market share, 2024)

• Top Delivery Format: Oral Supplements (55% market share, 2024)

• Leading Application: General Wellness (50% market share, 2024)

• Top End-User: Individual Consumers (60% market share, 2024)

• Over 26 million adults in the U.S. have used at-home genetic testing kits for supplement and nutrition decisions.

Revenue Breakdown Table

Artificial intelligence today fuels the most significant breakthroughs in the personalized testing and supplements sector. AI-driven analytics enable firms to decode genetic, metabolic, and lifestyle data, transforming raw biometrics into actionable health advice and bespoke supplement recommendations.

Companies such as Viome, InsideTracker, and LifeNome leverage AI to integrate DNA sequence analysis, microbiome insight, and biomarker concentration, allowing nutritionists and health brands to target individual deficiencies with unprecedented accuracy. From instant dietary feedback to lifelong health optimization, the fusion of AI and precision health brings scalable personalization to consumers everywhere, making wellness truly individual.

What sets this AI revolution apart is its ability to combine real-time data from wearables, apps, and test kits with advanced machine learning. By predicting personal responses to ingredients and interventions, AI empowers dynamic nutrition plans and curated supplement packs. Personalization platforms, now adopted worldwide, are continually learning, adapting, and improving outcomes for users through direct-to-consumer models, telehealth, and at-home diagnostics.

What Is Fueling Market Growth So Fast?

• Consumer Awareness: People now understand how genetics, nutrition, and lifestyle interact—the surge in DNA-based tests and custom supplements reflects a shift from generic to individualized wellness.

• Tech Integration: Advancements in AI, mobile health apps, and smart wearables mean that personalized insights and continual feedback are easier to access than ever before.

• Investment in Nutrigenomics: NIH’s $170 million investment and expanding public/private research commitments highlight massive global progress in genotype-driven nutrition science.

• Regulatory Clarity: Robust frameworks in North America, Europe, and Asia Pacific ensure consumer safety and build market trust—spurring adoption and innovation.

Opportunity & Trend Questions: Is Personalized Nutrition Here to Stay?

How Are Data and Digital Health Expanding the Personalized Supplements Opportunity?

With 388 million annual digital health app downloads reported globally and health app spending up 19% to $377 million, the rise of connected wellness is unstoppable. Consumers increasingly use digital tools to track genetic test results, supplement regimens, and even receive AI-powered health guidance—a clear sign that data-centric personalization is not just a trend, but a new standard in healthy living.

Will Asian Markets Lead the Next Chapter of Growth?

Asia Pacific’s growth surge fuelled by digitization, urbanization, and the region’s expanding middle class—is setting new records. China’s adoption of home testing kits by more than 3.2 million users in 2022 illustrates how rising digital penetration and health awareness are driving long-term, sustainable market expansion. Regional governments and technology-driven startups actively invest in microbiome research and wellness platforms, signalling a future where Asian markets could rival North American pioneers in personalized health adoption.

Regional & Segment Analysis

North America Remains Supreme, Asia Pacific Surges

• North America (2024): Led by the U.S., with $1.66 billion market value, accounts for the largest share high disposable income, technological expertise, and FDA/FTC/CLIA regulatory support are key drivers.

• Asia Pacific: Fastest-growing region as smartphone penetration, middle class expansion, and health awareness rise—China leads momentum with strong government backing and young millennial adoption.

• Europe: Germany stands out for its proactive approach, broad healthcare infrastructure, and technology awareness, sustaining positive uptake across the continent.

Segmentation Breakdown

• Product Type: Nutrition supplements lead (65% share, 2024); testing kits growing fastest (35% share, forecast).

• Service Type: Genetic testing services dominate (40% share); consultation/personalized recommendations surge via telehealth (30% forecast).

• Delivery Format: Oral supplements top (55% share), functional foods/beverages expand fastest, driven by taste-masking tech and ready-to-drink convenience.

• Application: General wellness prevails (50% share), while sports & fitness applications see the strongest CAGR due to performance optimization trends.

• End-User: Individual consumers remain the largest group (60% share), healthcare and clinics accelerate with genomic-driven therapeutics.

Latest Breakthroughs & Top Companies

Recent launches and partnerships are redefining the landscape:

• Sova Health (India, April 2025): Launched proprietary gut microbiome and food intolerance tests, leveraging India’s largest microbiome database (35,000+ samples).

• InnerBuddies (Netherlands, Sep 2025): Debuted a gut health ‘operating system’ dashboard with advanced analytics and microbiome science for tailored solutions.

• Ultrahuman (India, Oct 2025): Rolled out Vision Cloud, the world’s first free universal health report interpreter—making long-term trend analysis accessible to millions.

• Nutrafol (USA, Sep 2025): Partnered with MLB as the Official Hair Growth Partner, targeting fan engagement and athlete health.

Top Companies

23andMe, AncestryDNA, Viome, MyHeritage, Color Genomics, Invitae, Helix, Fulgent Genetics, Nutrigenomix, InsideTracker, DNAfit, Care/of, Persona Nutrition, Baze, Rootine, Pharmavite (Nature Made), GNC Holdings, The Vitamin Shoppe, Nestle Health Science (Persona Nutrition, Garden of Life, Vital Proteins), myDNA, LifeNome, Everlywell, Nutrisystem, Nutrigenomix Inc., Orig3n, Anatolia Nutrition, Nutritional Growth Solutions, Nutritional Genomics.

Challenges & Cost Pressures

Despite the optimism, the market grapples with high costs for advanced testing and supplements, regulatory complexities across geographies, and issues related to consumer education on genetic privacy, efficacy, and outcome tracking. Manufacturers face pressures to provide validated, credible claims amidst shifting compliance requirements, while regional disparity in digital access and healthcare infrastructure presents headwinds for global adoption.

Case Study: India’s Sova Health—Microbiome-Driven Precision

India’s Sova Health exemplifies the future of precision testing. Using its proprietary gut microbiome database, Sova Health delivers targeted probiotic and food intolerance solutions. The scalability and clinical accuracy of its technology are driving adoption among consumers who seek root-cause insights for metabolic, immune, and mental health, showcasing how localized innovation meets global standards in the personalized wellness era.

Read Also: Circulating Biomarkers Market

You can place an order or ask any questions. Please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344